Neurite outgrowth can be modulated in vitro using a tetracycline-repressible gene therapy vector expressing human nerve growth factor.

作者: Armin Blesch , Hua S. Uy , Nicole Diergardt , Mark H. Tuszynski

DOI: 10.1002/(SICI)1097-4547(20000201)59:3<402::AID-JNR14>3.0.CO;2-Q

关键词: BiologyNeurotrophinNervous systemNeuroscienceIn vivoGene productGene expressionNeurotrophic factorsNerve growth factorCell biologyNeurite

摘要: The delivery of neurotrophic factors to the adult nervous system has potential applications for treatment neurodegenerative diseases and trauma. In vivo ex gene therapy offer a means delivering growth other therapeutic substances central (CNS) in an intraparenchymal, accurately targeted, regionally restricted manner. Ideally, systems should also be regulatable, allowing exogenous control amount product delivery. present experiment, tetracycline-regulatable expression was generated determine whether controllable release nerve factor (NGF) green fluorescent protein (GFP) from primary rat fibroblasts could modulate biological responses (neurite outgrowth) vitro. Using tetracycline-repressible construct, it found that NGF mRNA, protein, NGF-induced neurite outgrowth tightly regulated within 24 hour period, dose-dependent fashion, by exposure tetracycline analog doxycycline. Similarly, levels fluorescence GFP-transfected cells. These findings neurobiological lay framework future studies using neurotrophin models CNS injury.

参考文章(41)
Fred H. Gage, Michael B. Rosenberg, Mark H. Tuszynskil, Kazunari Yoshida, David M. Armstrong, Robert C. Hayes, Theodore Friedmann, Chapter 17 Gene therapy in the CNS: Intracerebral grafting of genetically modified cells Progress in Brain Research. ,vol. 86, pp. 205- 217 ,(1990) , 10.1016/S0079-6123(08)63178-7
H.K. Raymon, S. Thode, F.H. Gage, Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease Experimental Neurology. ,vol. 144, pp. 82- 91 ,(1997) , 10.1006/EXNR.1996.6392
Armin Blesch, Ray J. Grill, Mark H. Tuszynski, Chapter 32 Neurotrophin gene therapy in CNS models of trauma and degeneration Progress in Brain Research. ,vol. 117, pp. 473- 484 ,(1998) , 10.1016/S0079-6123(08)64033-9
A.Dusty Miller, Daniel G. Miller, J. Victor Garcia, Carmel M. Lynch, Use of retroviral vectors for gene transfer and expression. Methods in Enzymology. ,vol. 217, pp. 581- 599 ,(1993) , 10.1016/0076-6879(93)17090-R
R. Grill, K. Murai, A. Blesch, F. H. Gage, M. H. Tuszynski, Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury The Journal of Neuroscience. ,vol. 17, pp. 5560- 5572 ,(1997) , 10.1523/JNEUROSCI.17-14-05560.1997
Jacques P. Delort, Mario R. Capecchi, TAXI/UAS: A molecular switch to control expression of genes in vivo. Human Gene Therapy. ,vol. 7, pp. 809- 820 ,(1996) , 10.1089/HUM.1996.7.7-809
Mark H Tuszynski, Katie Gabriel, Fred H Gage, Steve Suhr, Scott Meyer, Angela Rosetti, None, Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury Experimental Neurology. ,vol. 137, pp. 157- 173 ,(1996) , 10.1006/EXNR.1996.0016
Victor M. Rivera, Tim Clackson, Sridaran Natesan, Roy Pollock, Jane F. Amara, Terence Keenan, Shannon R. Magari, Tom Phillips, Nancy L. Courage, Franklin Cerasoli, Dennis A. Holt, Michael Gilman, A HUMANIZED SYSTEM FOR PHARMACOLOGIC CONTROL OF GENE EXPRESSION Nature Medicine. ,vol. 2, pp. 1028- 1032 ,(1996) , 10.1038/NM0996-1028
Xuehai Ye, Victor M Rivera, Philip Zoltick, Franklin Cerasoli Jr, Michael A Schnell, Guang-ping Gao, Joseph V Hughes, Michael Gilman, James M Wilson, Regulated Delivery of Therapeutic Proteins After in Vivo Somatic Cell Gene Transfer Science. ,vol. 283, pp. 88- 91 ,(1999) , 10.1126/SCIENCE.283.5398.88
S. T. Suhr, F. H. Gage, Gene Therapy for Neurologic Disease JAMA Neurology. ,vol. 50, pp. 1252- 1268 ,(1993) , 10.1001/ARCHNEUR.1993.00540110122012